Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311125890> ?p ?o ?g. }
- W4311125890 endingPage "446" @default.
- W4311125890 startingPage "435" @default.
- W4311125890 abstract "To examine delayed effects of theta-beta ratio (TBR) neurofeedback (NF) for attention-deficit/hyperactivity disorder (ADHD) 25 months after baseline, ∼21 months after end of treatment.Children aged 7 to 10 years with rigorously diagnosed ADHD had been randomized to 38 sessions of TBR NF (n = 84) or control treatment (n = 58) of identical appearance, intensity/frequency, and duration, differing only in that reinforcement for controls was based on a pre-recorded electroencephalogram (EEG) of another child. Child, parent, and all site staff were blinded until after 25-month assessments, with only one-fourth able to guess the control treatment correctly. Baseline assessments were repeated off medication after 25 months.Of the 142 participants, 120 had 25-month follow-up (84.5% retention). Only 12 participants (6 controls) had NF after the study treatment, greatly retaining the randomization. The primary outcome, parent-rated inattention, was not significantly different between treatments despite large pre-post effect sizes (NF recipients, d = 1.63; controls, d = 1.42). Most secondary measures showed the same pattern. Response rates (Clinical Global Impression-Improvement ≤2) were 58.6% of NF recipients and 66% of controls (not significant). Marginally more controls than NF recipients needed medication (57.1% vs 38.6%, p = .059); specifically, 7.1% of NF recipients and 4% of controls had reduced medication need, whereas 34.3% of NF recipients and 50% of controls needed more medication (p = 0.084).Most of the large within-group improvement from the NF treatment package reported by unblinded studies and replicated in this blinded study reflects nonspecific effects, not specific effects of deliberate down-training of EEG theta-beta power ratio. At 25-month follow-up, it appears comparable to the evidence-based Multimodal Treatment Study of ADHD (MTA) treatments, suggesting a psychotherapeutic/behavioral effect.Double-Blind 2-Site Randomized Clinical Trial of Neurofeedback for ADHD; http://clinicaltrials.gov/; NCT02251743.We worked to ensure sex and gender balance in the recruitment of human participants. We worked to ensure race, ethnic, and/or other types of diversity in the recruitment of human participants. We worked to ensure that the study questionnaires were prepared in an inclusive way. One or more of the authors of this paper self-identifies as a member of one or more historically underrepresented sexual and/or gender groups in science. We actively worked to promote sex and gender balance in our author group." @default.
- W4311125890 created "2022-12-23" @default.
- W4311125890 creator A5000585575 @default.
- W4311125890 creator A5001969567 @default.
- W4311125890 creator A5019758372 @default.
- W4311125890 creator A5023681590 @default.
- W4311125890 creator A5028348383 @default.
- W4311125890 creator A5030371916 @default.
- W4311125890 creator A5036196228 @default.
- W4311125890 creator A5046251977 @default.
- W4311125890 creator A5055238312 @default.
- W4311125890 creator A5055575007 @default.
- W4311125890 creator A5059921483 @default.
- W4311125890 creator A5068382742 @default.
- W4311125890 creator A5073738374 @default.
- W4311125890 creator A5082292175 @default.
- W4311125890 creator A5085696683 @default.
- W4311125890 creator A5085837797 @default.
- W4311125890 creator A5087993762 @default.
- W4311125890 creator A5089267730 @default.
- W4311125890 creator A5090244595 @default.
- W4311125890 date "2023-04-01" @default.
- W4311125890 modified "2023-10-15" @default.
- W4311125890 title "Neurofeedback for Attention-Deficit/Hyperactivity Disorder: 25-Month Follow-up of Double-Blind Randomized Controlled Trial" @default.
- W4311125890 cites W1971487456 @default.
- W4311125890 cites W1973452489 @default.
- W4311125890 cites W2005908650 @default.
- W4311125890 cites W2031947904 @default.
- W4311125890 cites W2032626760 @default.
- W4311125890 cites W2071199156 @default.
- W4311125890 cites W2074447260 @default.
- W4311125890 cites W2078339393 @default.
- W4311125890 cites W2113390523 @default.
- W4311125890 cites W2116228932 @default.
- W4311125890 cites W2131099228 @default.
- W4311125890 cites W2141797822 @default.
- W4311125890 cites W2154442999 @default.
- W4311125890 cites W2280670319 @default.
- W4311125890 cites W2412560454 @default.
- W4311125890 cites W2518157807 @default.
- W4311125890 cites W2601578636 @default.
- W4311125890 cites W2739370865 @default.
- W4311125890 cites W2968111141 @default.
- W4311125890 cites W2981081124 @default.
- W4311125890 cites W3080886168 @default.
- W4311125890 cites W4230392826 @default.
- W4311125890 cites W4310708187 @default.
- W4311125890 cites W4311692290 @default.
- W4311125890 doi "https://doi.org/10.1016/j.jaac.2022.07.862" @default.
- W4311125890 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36521694" @default.
- W4311125890 hasPublicationYear "2023" @default.
- W4311125890 type Work @default.
- W4311125890 citedByCount "2" @default.
- W4311125890 countsByYear W43111258902023 @default.
- W4311125890 crossrefType "journal-article" @default.
- W4311125890 hasAuthorship W4311125890A5000585575 @default.
- W4311125890 hasAuthorship W4311125890A5001969567 @default.
- W4311125890 hasAuthorship W4311125890A5019758372 @default.
- W4311125890 hasAuthorship W4311125890A5023681590 @default.
- W4311125890 hasAuthorship W4311125890A5028348383 @default.
- W4311125890 hasAuthorship W4311125890A5030371916 @default.
- W4311125890 hasAuthorship W4311125890A5036196228 @default.
- W4311125890 hasAuthorship W4311125890A5046251977 @default.
- W4311125890 hasAuthorship W4311125890A5055238312 @default.
- W4311125890 hasAuthorship W4311125890A5055575007 @default.
- W4311125890 hasAuthorship W4311125890A5059921483 @default.
- W4311125890 hasAuthorship W4311125890A5068382742 @default.
- W4311125890 hasAuthorship W4311125890A5073738374 @default.
- W4311125890 hasAuthorship W4311125890A5082292175 @default.
- W4311125890 hasAuthorship W4311125890A5085696683 @default.
- W4311125890 hasAuthorship W4311125890A5085837797 @default.
- W4311125890 hasAuthorship W4311125890A5087993762 @default.
- W4311125890 hasAuthorship W4311125890A5089267730 @default.
- W4311125890 hasAuthorship W4311125890A5090244595 @default.
- W4311125890 hasConcept C118552586 @default.
- W4311125890 hasConcept C126322002 @default.
- W4311125890 hasConcept C142724271 @default.
- W4311125890 hasConcept C15744967 @default.
- W4311125890 hasConcept C168563851 @default.
- W4311125890 hasConcept C1862650 @default.
- W4311125890 hasConcept C187212893 @default.
- W4311125890 hasConcept C204243189 @default.
- W4311125890 hasConcept C204787440 @default.
- W4311125890 hasConcept C2434490 @default.
- W4311125890 hasConcept C27081682 @default.
- W4311125890 hasConcept C2776000289 @default.
- W4311125890 hasConcept C2780783007 @default.
- W4311125890 hasConcept C522805319 @default.
- W4311125890 hasConcept C548259974 @default.
- W4311125890 hasConcept C71924100 @default.
- W4311125890 hasConceptScore W4311125890C118552586 @default.
- W4311125890 hasConceptScore W4311125890C126322002 @default.
- W4311125890 hasConceptScore W4311125890C142724271 @default.
- W4311125890 hasConceptScore W4311125890C15744967 @default.
- W4311125890 hasConceptScore W4311125890C168563851 @default.
- W4311125890 hasConceptScore W4311125890C1862650 @default.
- W4311125890 hasConceptScore W4311125890C187212893 @default.
- W4311125890 hasConceptScore W4311125890C204243189 @default.